SCHEMBL27466693

SCHEMBL27466693

C=CC(c1ccsc1COc1ccc(C)cc1)S(=O)(=O)n1cccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 2/20 0.37
EDNRA P25101 2/20 0.37
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
TSHR P16473 2/20 0.33
ATM Q13315 1/20 0.33
MAPT P10636 2/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
TRPM8 Q7Z2W7 2/20 0.32
HPGD P15428 1/20 0.32
LMNA P02545 1/20 0.32
AR P10275 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27473940 0.76
SCHEMBL27473552 0.75 EDNRB (0.36) EDNRBEDNRASMN1; SMN2ALDH1A1CA1
SCHEMBL27572608 0.71 CA1 (0.46) CA1CA2LMNAGAA
SCHEMBL27452907 0.70
SCHEMBL27457259 0.70 SMN1; SMN2 (0.43) NPC1RAB9ATSHRMAPTPOLB
SCHEMBL4630655 0.65 EDNRB (0.54) EDNRBEDNRANPC1RAB9ATSHR
SCHEMBL27544498 0.65 CA1 (0.37) CA1CA2
SCHEMBL19243090 0.59 SMN1; SMN2 (0.40) EDNRBEDNRANPC1RAB9ATSHR
SCHEMBL27468572 0.59 MAPT (0.32) MAPTTP53ALDH1A1TDP1HPGD
SCHEMBL4631580 0.58 EDNRB (0.47) EDNRBEDNRATSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1636994-B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby ENCYSIVE PHARMACEUTICALS INC 2010-05-12 CN disclosed
CN-1636994-A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby ENCYSIVE PHARMACEUTICALS INC (US) 2005-07-13 CN disclosed
CN-1179961-C Sulfonamides for the treatment of endothelin mediated diseases ��ɪϣ����ҩ��˾ 2004-12-15 CN disclosed
CN-1130355-C Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORP (US) 2003-12-10 CN disclosed
CN-1253560-A Sulfonamides for the treatment of endothelin mediated diseases TEXA BIOTECHNOLOGY CORP (US) 2000-05-17 CN disclosed
CN-1184470-A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORP (US) 1998-06-10 CN disclosed